ADHD
Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.
CompletedNCT04832737
Official study titleCould a Strength- Based Treatment Improve Self-management in Adults With Attention Deficit Hyperactivity Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including HuddersfieldADHDBehavioural studyAges 18–80
- Countries
- United Kingdom
- Sponsor
- University of Huddersfield
CompletedNCT01682915
Official study titleStructural and Functional Connectivity of Frontostriatal and Frontoparietal Networks as Endophenotypes of Attention-deficit Hyperactivity Disorder
This study has finished and is no longer accepting participants.
In TaipeiADHDObservational studyAges 12–20
- Countries
- Taiwan
- Sponsor
- National Taiwan University Hospital
CompletedNCT00553319
Official study titleA Randomized, Double-Blind, Placebo-Controlled Study of Mixed Amphetamine Salts (Adderall-XR) for the Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) and Cocaine Dependence
This study has finished and is no longer accepting participants.
Multiple locations, including MinneapolisADHDMedication studyAges 18–60
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
CompletedNCT00221962
Official study titleThe Cognitive Effects of Aripiprazole in Children
This study has finished and is no longer accepting participants.
In ClevelandADHDMedication studyAges 8–12
- Countries
- United States
- Sponsor
- University Hospitals Cleveland Medical Center
TerminatedNCT06215144
What is this study about?This study evaluates the safety and effectiveness of NRCT-101SR for people with ADHD.
This study ended early.
Multiple locations, including AnaheimADHDMedication studyAges 13–17
- Countries
- United States
- Sponsor
- Neurocentria, Inc.
CompletedNCT00343811
What is this study about?This study evaluated the effectiveness of Modafinil for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockADHDMedication studyAges 6–17
- Countries
- United States
- Sponsor
- Cephalon
TerminatedNCT03523663
Official study titleAlgorithm to Quantitatively Determine the Ideal Drug Dose to Treat Attention Deficit Hyperactivity Disorder
This study ended early.
In MadisonADHDObservational studyAges 8–12
- Countries
- United States
- Sponsor
- University of Wisconsin, Madison
CompletedNCT01052753
Official study titleThe Association Between Executive Functions and Candidate Genes of Dopaminergic and Noradrenergic Systems in Attention-deficit Hyperactivity Disorder
This study has finished and is no longer accepting participants.
In TaipeiADHDObservational studyAges 7–18
- Countries
- Taiwan
- Sponsor
- National Taiwan University Hospital
CompletedNCT01554046
Official study titleThe Effect of Methylphenidate (Ritalin IR) Treatment in Familial Attention Deficit/Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
In Ramat GanADHDMedication studyAges 6–65
- Countries
- Israel
- Sponsor
- Sheba Medical Center
CompletedNCT06844812
This study has finished and is no longer accepting participants.
In IstanbulADHDObservational studyAges 6–11
- Countries
- Türkiye
- Sponsor
- Saglik Bilimleri Universitesi
CompletedNCT00917371
Official study titleThe Effectiveness of Atomoxetine on Brain Imaging, Neuropsychological, and Social Functions in Adults With Attention Deficit/Hyperactivity Disorder
This study has finished and is no longer accepting participants.
In TaipeiADHDObservational studyAges 18–50
- Countries
- Taiwan
- Sponsor
- National Taiwan University Hospital
CompletedNCT01554462
Official study titleThe Effects of Eicosapentaenoic Acid (EPA)/ Docosahexaenoic Acid (DHA) Supplementation on Cognitive Control in Children With Attention Deficit Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
In UtrechtADHDPlacebo comparisonAges 8–12
- Countries
- Netherlands
- Sponsor
- Unilever R&D